Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
about
MDMA and the “Ecstasy Paradigm”The Potential Dangers of Using MDMA for PsychotherapyCortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users.Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research.Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study.Ecstasy: are animal data consistent between species and can they translate to humans?Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.Persistent neuropsychological problems after 7 years of abstinence from recreational Ecstasy (MDMA): a case study.Preventing problems in Ecstasy users: reduce use to reduce harm.Understanding the Global Problem of Drug Addiction is a Challenge for IDARS ScientistsMDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI studyOral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques.Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.Learning, Memory, and Executive Function in New MDMA Users: A 2-Year Follow-Up Study.MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.Paradoxical effects of low dose MDMA on latent inhibition in the ratDance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changesReward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.Meta-analysis of executive functioning in ecstasy/polydrug usersNeuropsychological function in ecstasy users: a study controlling for polydrug use.The effects of 'ecstasy' (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses.MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy.fNIRS suggests increased effort during executive access in ecstasy polydrug users.ERP evidence suggests executive dysfunction in ecstasy polydrug users.Recreational 3,4-methylenedioxymethamphetamine or 'ecstasy': Current perspective and future research prospects.Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.Everyday memory deficits in ecstasy-polydrug users.Chronic cognitive impairment in users of 'ecstasy' and cannabis.Dysfunctional overnight memory consolidation in ecstasy users.Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.What is a dose of ecstasy?Selective neurocognitive deficits associated with multiple doses of ecstasy/MDMA: a reply to Cole.Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.Is emotional intelligence impaired in ecstasy-polydrug users?Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective.Cortical oxygenation suggests increased effort during cognitive inhibition in ecstasy polydrug users.Electrophysiological indices of response inhibition in human polydrug users.Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
P2860
Q21558618-4F64D6C3-46E7-4495-AE8C-19FEA3D308ABQ21558619-13EB0793-6B73-4AAB-9B7E-A7867709B5C9Q30478967-558A7056-6AB1-42E4-9C4A-13D2AB89419DQ30561321-8410816E-1B9C-47BD-8539-14EA72328677Q31005994-BE42122E-7106-4D07-B0B1-18762F1C1256Q31033315-C00A916E-F755-4B83-BFF1-B5C60E055F92Q34359604-6C05B89A-FDDC-4A0E-9544-37D67F4C4A07Q34551564-196C50EE-20B3-4150-AC7F-923A33107B71Q35105557-9F1A330C-5EA6-4C1B-86DD-CECCCCCADA45Q35107815-F59F5243-E0F7-40AF-9F7B-FDF560FA54FFQ35415158-EB9C3436-3298-463F-8D34-7D812154C95AQ35989723-B7B241D2-4686-4553-B499-8DCF28FE5A4EQ36020276-593CAF00-711C-4B34-A91E-6AD1AA396FD1Q36352968-7617F6DC-BB3A-437C-8E89-C7BBD15B1FE8Q36410784-0ACAA87B-F1F3-4D96-8042-780D33BCE8F9Q36410792-8AE79FA8-F749-452A-8490-211440426A2EQ36615013-9934D851-2A75-4529-8D81-9AE82473A8E0Q36617655-69F5C218-652B-45F8-926D-902E4875A8BAQ36803318-70CD485D-E197-468D-A418-15F1D3DCCC2BQ36919640-B957FE14-70B3-4EAD-833E-1ACB483292C6Q37123827-0B8DC4FF-F5E3-4960-86E0-C5B17797B317Q37990456-8FF0F7AD-C2F3-4C78-8561-B53EE80F9CA0Q38178521-0B88C303-EA6A-40CC-9FDF-97F2392FEA3DQ38420994-18995A31-4A82-4CFB-9418-0F3A995F5CD1Q38453920-D78A1C49-B559-4405-A73C-2547E2D04F61Q38665183-CA23BF27-3FC5-46C4-B88B-2D6365CAB0A4Q39026719-CD5EF72F-A772-444B-8650-34949BFC5D90Q40198290-F1B98888-FD82-4A9B-B86E-D8F695E316E8Q41848657-FEABB3A5-74FE-4312-8401-EE4F91E73628Q42706480-63581FFF-F544-4153-9E70-089394DF2B3DQ43096892-C8DEEBF4-EF1A-4CE0-AE5A-C02402A97DF7Q44048487-66263205-91DE-4E4E-849E-98BDBDFD18FCQ44518154-9F335C7F-31C3-40E2-9BFA-26FAB7D2EEA3Q44761161-A4AE9900-5AA8-4988-BB62-1651DEE0FA83Q46359381-586E4200-AAE5-4746-8634-D2B0A186E2F9Q46477501-23D37B58-025E-43BD-B4CF-4E00B3D7E248Q46970747-E633C554-D875-495C-9AB0-1AA3DF9B9E18Q47940965-CD55E55C-5F6C-4C9B-9358-E2B106F9CDB9Q48169132-56223BF2-EE05-4C5E-91D0-4433BF3904A2Q48598882-AD837E71-B4F4-43E8-879B-355BD822695E
P2860
Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Ecstasy use: cognitive deficit ...... d problematic use of the drug.
@en
Ecstasy use: cognitive deficit ...... d problematic use of the drug.
@nl
type
label
Ecstasy use: cognitive deficit ...... d problematic use of the drug.
@en
Ecstasy use: cognitive deficit ...... d problematic use of the drug.
@nl
prefLabel
Ecstasy use: cognitive deficit ...... d problematic use of the drug.
@en
Ecstasy use: cognitive deficit ...... d problematic use of the drug.
@nl
P2093
P2860
P1476
Ecstasy use: cognitive deficit ...... d problematic use of the drug.
@en
P2093
P2860
P304
P356
10.1177/026988110101500406
P407
P577
2001-12-01T00:00:00Z